Single and Multiple-Ascending Dose Study of CRN00808 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

September 22, 2017

Primary Completion Date

April 30, 2018

Study Completion Date

April 30, 2018

Conditions
Healthy Volunteers
Interventions
DRUG

CRN00808

Investigational drug

DRUG

Placebo Oral Solution

Placebo

DRUG

Midazolam oral solution

Midazolam as part of the drug-drug interaction arm of the study

DRUG

Placebo oral capsule

Placebo

Trial Locations (1)

Unknown

Nucleus Network, Melbourne

Sponsors
All Listed Sponsors
lead

Crinetics Pharmaceuticals Inc.

INDUSTRY

NCT03276858 - Single and Multiple-Ascending Dose Study of CRN00808 in Healthy Volunteers | Biotech Hunter | Biotech Hunter